Loading...
XNAS
HCAT
Market cap272mUSD
Jul 29, Last price  
3.92USD
1D
-4.16%
1Q
-0.76%
IPO
-89.77%
Name

Health Catalyst Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.89
EPS
Div Yield, %
Shrs. gr., 5y
26.28%
Rev. gr., 5y
14.62%
Revenues
307m
+3.60%
73,081,000112,574,000154,941,000188,845,000241,926,000276,236,000295,938,000306,584,000
Net income
-70m
L-41.17%
-47,035,000-61,984,000-60,096,000-115,017,000-153,210,000-137,403,000-118,147,000-69,502,000
CFO
15m
P
-36,829,000-40,296,000-32,184,000-26,148,000-23,123,000-35,270,000-33,080,00014,559,000
Earnings
Aug 05, 2025

Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
IPO date
Jul 25, 2019
Employees
1,200
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
306,584
3.60%
295,938
7.13%
276,236
14.18%
Cost of revenue
334,959
380,612
367,944
Unusual Expense (Income)
NOPBT
(28,375)
(84,674)
(91,708)
NOPBT Margin
Operating Taxes
333
356
(4,280)
Tax Rate
NOPAT
(28,708)
(85,030)
(87,428)
Net income
(69,502)
-41.17%
(118,147)
-14.01%
(137,403)
-10.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,808)
(4,424)
BB yield
0.35%
0.77%
Debt
Debt current
234,796
6,716
3,434
Long-term debt
36,196
266,744
265,991
Deferred revenue
249
77
105
Other long-term liabilities
151,332
74
121
Net debt
(121,008)
(44,268)
(94,065)
Cash flow
Cash from operating activities
14,559
(33,080)
(35,270)
CAPEX
(1,616)
(1,236)
(17,414)
Cash from investing activities
(22,902)
20,293
(39,021)
Cash from financing activities
151,746
2,730
(2,613)
FCF
(30,521)
(82,083)
(85,565)
Balance
Cash
392,000
317,728
363,490
Long term investments
Excess cash
376,671
302,931
349,678
Stockholders' equity
365,207
366,919
425,010
Invested Capital
402,668
316,565
323,532
ROIC
ROCE
EV
Common stock shares outstanding
60,185
56,418
54,080
Price
7.07
-23.65%
9.26
-12.89%
10.63
-73.17%
Market cap
425,508
-18.55%
522,434
-9.12%
574,868
-69.45%
EV
304,500
478,166
480,803
EBITDA
13,056
(42,451)
(43,411)
EV/EBITDA
23.32
Interest
637
7,287
1,678
Interest/NOPBT